Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - BIOLARGO, INC. | ex_180957.htm |
| EX-5.1 - EXHIBIT 5.1 - BIOLARGO, INC. | ex_180937.htm |
| S-1 - FORM S-1 - BIOLARGO, INC. | blgo20200410_s1.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
BioLargo, Inc.
We consent to the inclusion in this Registration Statement on Form S-1 of BioLargo, Inc. (the “Company”) of our report dated March 31, 2020, relating to our audits of the Company’s consolidated financial statements as of December 31, 2018 and 2019 and for the years then ended, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Our report dated March 31, 2020 contains an explanatory paragraph that states the Company has experienced recurring losses, negative cash flows from operations, has limited capital resources, and a net stockholders’ deficit. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
We also consent to the reference to our Firm under the heading “Experts” in this Registration Statement on Form S-1.
/s/Haskell & White LLP
HASKELL & WHITE LLP
Irvine, California
April 10, 2020